574 related articles for article (PubMed ID: 11372683)
1. Evidence for a role for phospholipase C, but not phospholipase A2, in platelet activation in response to low concentrations of collagen.
Lockhart LK; Pampolina C; Nickolaychuk BR; McNicol A
Thromb Haemost; 2001 May; 85(5):882-9. PubMed ID: 11372683
[TBL] [Abstract][Full Text] [Related]
2. A role for p38 MAP kinase in platelet activation by von Willebrand factor.
Canobbio I; Reineri S; Sinigaglia F; Balduini C; Torti M
Thromb Haemost; 2004 Jan; 91(1):102-10. PubMed ID: 14691575
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of collagen-induced platelet activation by arachidonyl trifluoromethyl ketone.
McNicol A; Nickolaychuk BR
Biochem Pharmacol; 1995 Nov; 50(11):1795-802. PubMed ID: 8615857
[TBL] [Abstract][Full Text] [Related]
4. The effects of an inhibitor of diglyceride lipase on collagen-induced platelet activation.
Jackson EC; Ortar G; McNicol A
J Pharmacol Exp Ther; 2013 Dec; 347(3):582-8. PubMed ID: 24042163
[TBL] [Abstract][Full Text] [Related]
5. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
Lockhart LK; McNicol A
J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation and activation of cytosolic phospholipase A2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets.
Börsch-Haubold AG; Kramer RM; Watson SP
Eur J Biochem; 1997 May; 245(3):751-9. PubMed ID: 9183015
[TBL] [Abstract][Full Text] [Related]
7. Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: biochemical regulatory mechanisms.
Moscardó A; Vallés J; Latorre A; Madrid I; Santos MT
Thromb Res; 2013 Apr; 131(4):e154-9. PubMed ID: 23352311
[TBL] [Abstract][Full Text] [Related]
8. Low concentrations of reactive gamma-ketoaldehydes prime thromboxane-dependent human platelet aggregation via p38-MAPK activation.
Bernoud-Hubac N; Alam DA; Lefils J; Davies SS; Amarnath V; Guichardant M; Roberts LJ; Lagarde M
Biochim Biophys Acta; 2009 Apr; 1791(4):307-13. PubMed ID: 19233311
[TBL] [Abstract][Full Text] [Related]
9. Involvement of phospholipase C-gamma2 in activation of mitogen-activated protein kinase and phospholipase A2 by zooxanthellatoxin-A in rabbit platelets.
Rho MC; Nakahata N; Nakamura H; Murai A; Ohizumi Y
J Pharmacol Exp Ther; 1997 Jul; 282(1):496-504. PubMed ID: 9223592
[TBL] [Abstract][Full Text] [Related]
10. Anisomycin does not activate p38MAPK in human platelets.
Pampolina C; McNicol A
Thromb Res; 1999 Oct; 96(1):27-35. PubMed ID: 10554082
[TBL] [Abstract][Full Text] [Related]
11. Cytosolic phospholipase A2 is phosphorylated in collagen- and thrombin-stimulated human platelets independent of protein kinase C and mitogen-activated protein kinase.
Börsch-Haubold AG; Kramer RM; Watson SP
J Biol Chem; 1995 Oct; 270(43):25885-92. PubMed ID: 7592775
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP.
Shen MY; Hsiao G; Liu CL; Fong TH; Lin KH; Chou DS; Sheu JR
Br J Haematol; 2007 Nov; 139(3):475-85. PubMed ID: 17868048
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin receptor blocker losartan suppresses platelet activity by interfering with thromboxane signaling.
Schwemmer M; Sommer O; Bassenge E
Cardiovasc Drugs Ther; 2001 Jul; 15(4):301-7. PubMed ID: 11800413
[TBL] [Abstract][Full Text] [Related]
14. Platelet activation by tetraprenol via stimulation of phospholipase A2 action.
Nakano T; Matsumoto S; Hanasaki K; Arita H
J Biochem; 1989 Nov; 106(5):887-93. PubMed ID: 2533198
[TBL] [Abstract][Full Text] [Related]
15. Skepinone-L, a novel potent and highly selective inhibitor of p38 MAP kinase, effectively impairs platelet activation and thrombus formation.
Borst O; Walker B; Münzer P; Russo A; Schmid E; Faggio C; Bigalke B; Laufer S; Gawaz M; Lang F
Cell Physiol Biochem; 2013; 31(6):914-24. PubMed ID: 23817201
[TBL] [Abstract][Full Text] [Related]
16. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
17. Human group II 14 kDa phospholipase A2 activates human platelets.
Polgár J; Kramer RM; Um SL; Jakubowski JA; Clemetson KJ
Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):259-65. PubMed ID: 9355761
[TBL] [Abstract][Full Text] [Related]
18. Effects of the mitogen-activated protein (MAP) kinase kinase inhibitor 2-(2'-amino-3'-methoxyphenyl)-oxanaphthalen-4-one (PD98059) on human platelet activation.
McNicol A; Philpott CL; Shibou TS; Israels SJ
Biochem Pharmacol; 1998 Jun; 55(11):1759-67. PubMed ID: 9714293
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets.
Matsuoka I; Nakahata N; Nakanishi H
Biochem Pharmacol; 1989 Jun; 38(11):1841-7. PubMed ID: 2544181
[TBL] [Abstract][Full Text] [Related]
20. Cyclic nucleotides inhibit MAP kinase activity in low-dose collagen-stimulated platelets.
Jackson EC; McNicol A
Thromb Res; 2010 Feb; 125(2):147-51. PubMed ID: 19595442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
